| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 7,711,661 | 7,487,636 | 7,148,170 | 7,350,862 | | Cost of Revenue | 6,269,310 | 6,041,104 | 17,667,129 |
-
| | | Gross Profit | 1,442,351 | 1,446,532 | (10,518,959) | 7,350,862 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,063,803 | 1,098,943 | (10,877,293) | 6,954,523 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 58,014 | 59,808 | 56,126 | 53,458 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 320,534 | 287,781 | 302,208 | 342,881 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 320,534 | 287,781 | 302,208 | 342,881 | | Interest Expense | 26,772 | 26,735 | 19,348 | 17,867 | | Income Before Tax | 293,762 | 261,046 | 282,860 | 325,014 | | Income Tax Expense | 88,045 | 86,966 | 99,852 | 115,118 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 205,717 | 174,080 | 183,008 | 209,896 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 205,717 | 174,080 | 183,008 | 209,896 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $205,717 | $174,080 | $183,008 | $209,896 |
|
0.45% Nasdaq 
0.20%
Income Statement
